The detection of hyperphosphorylated tau in NFTs using PET radiotracers has evolved greatly in recent years, in part because of the failure of anti-amyloid therapies in AD and increasing evidence that tau may precede amyloid and trigger the AD process (Yoshida et al. 2019). This evidence concerns the gene MAPT and Alzheimer disease.